Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
elacridar (GF120918)
i
Other names:
GF120918, GW120918, GW0918
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(2)
News
Trials
Company:
GSK
Drug class:
P-glycoprotein inhibitor
Related drugs:
‹
oral paclitaxel/encequidar (1)
tetrandrine (0)
BAY 59-8862 (0)
oral paclitaxel/encequidar (1)
tetrandrine (0)
BAY 59-8862 (0)
›
Associations
(2)
News
Trials
VERI cancer hierarchy
Reset Filters
ABCG2 expression
Colorectal Cancer
ABCG2 expression
Colorectal Cancer
sunitinib + GF120918
Sensitive: D – Preclinical
sunitinib + GF120918
Sensitive
:
D
sunitinib + GF120918
Sensitive: D – Preclinical
sunitinib + GF120918
Sensitive
:
D
ABCB1 expression
Colorectal Cancer
ABCB1 expression
Colorectal Cancer
sunitinib + GF120918
Sensitive: D – Preclinical
sunitinib + GF120918
Sensitive
:
D
sunitinib + GF120918
Sensitive: D – Preclinical
sunitinib + GF120918
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login